Home » Topics » BioWorld Science

BioWorld Science
RSS

New 5-FU molecular combination merits further study

June 7, 1996

Development of AccuSite for basal cell carcinoma delayed

June 7, 1996

S-28828: 3M's imiquimod analogue

June 7, 1996

Controlled-release naproxen sodium now on U.S. shelves

June 7, 1996

Organon develops potent inhibitor of alpha-glucosidase I

June 7, 1996

Anika Research seeks European marketing approval for Orthovisc

June 7, 1996

Knoll describes antiarthritic and immunomodulator derivatives

June 7, 1996

Immunostimulating whole plant product undergoes clinical trials on AIDS patients

June 7, 1996

NSC-158393: Promising candidate for development as anti-AIDS drug

June 7, 1996

Fluorouracil/epinephrine injectable gel approved

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...